Sernova Company
Sernova develops regenerative medicine therapeutic technologies for treatment of chronic metabolic diseases.
Founded Date:
Undisclosed
Last Funding Type:
Post-IPO Equity
Headquarters:
Canada
Technology:
Regenerative Medicine
Employee Number:
1-10
Industry:
Regenerative Medicine
Estimated Revenue:
$100M to $500M
Number Of Exists:
Post-IPO Equity
Funding Status:
IPO
Investor Type:
Company
Investment Stage:
N/A
Total Funding:
$6.2M